LevelJump Announces Q2 Record Revenue
Rhea-AI Summary
LevelJump Healthcare (OTC: JMPHF, TSXV: JUMP) reported record Q2 2026 revenue of $5,008,038, up 6.7% from $4,692,007 in Q2 2025. Revenue for the six months ended June 30, 2026 was $9,738,438, a 5.0% increase from $9,273,503 a year earlier.
Quarterly growth was driven by imaging centres, with IHF imaging scan revenue rising to $2,544,018 from $2,348,610 (about 8.3% growth), while teleradiology (radiologist fee) revenue increased to $2,464,020 from $2,343,397 (up 5.1%). EBITDA for Q2 was $185,341, and for the six-month period $270,316. LevelJump reported a net loss of $484,544 for the quarter and $969,961 for the six months. According to LevelJump, the company remains focused on organic growth, expanding services and maximizing revenue opportunities across its CTS, ADC and diagnostic clinic operations.
Positive
- Q2 2026 revenue $5.01M, up 6.7% year over year
- Six-month revenue $9.74M, a 5.0% increase vs 2025
- IHF imaging revenue $2.54M in Q2, up about 8.3%
- Teleradiology revenue $2.46M in Q2, up 5.1%
- Q2 2026 EBITDA $185,341, with six-month EBITDA $270,316
Negative
- Net loss Q2 2026 $484,544 despite record revenue
- Six-month net loss $969,961 for period ended June 30, 2026
AI-generated analysis. How Rhea-AI works. Not financial advice.
Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the second quarter ended June 30, 2026.
The Company, through its CTS and ADC operations, had a strong quarter as demand continued increasing for our services. Our current focus remains on organic growth, expansion of services, and maximizing revenue opportunities.
Financial and Operational Highlights Include:
- Total revenues for the second quarter of 2026 were
$5,008,038 (2025:$4,692,007) a6.7% increase, and total revenues for the six months ended June 30, 2026, were$9,738,438 (2025:$9,273,503) a5.0% increase. - Revenue growth in the quarter was led by the Company's imaging centres. Revenue from imaging scans provided at the Company's IHF centres increased to
$2,544,018 (2025:$2,348,610) , an increase of approximately8.3% , while teleradiology (radiologist fee) revenue was$2,464,020 (2025:$2,343,397) an increase of5.1% . - Net loss for the 3 months was
$484,544 and for the six-month period was$969,961 . - EBITDA for the 3 months was
$185,341 and for the six-month period was$270,316 .
"This record quarter reflects solid execution of managements plans across all our operations," said Mitch Geisler, CEO. "Our imaging centres delivered
Non-IFRS Financial Measures
This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity.
For further details on the results, please refer to Leveljump's Management, Discussion and Analysis and Interim Condensed Consolidated Financial Statements for the quarter ended March 31, 2026, which are available on the Company's website (www.leveljumphealthcare.com) and under the Company's profile on SEDAR+ (www.sedarplus.ca).
About LevelJump Healthcare
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
Mitchell Geisler
Chief Executive Officer
info@leveljumphealthcare.com
647-340-2020
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/311357